IPOs

At the Eleventh Hour, Harpoon Therapeutics Signs up to Join the 2018 IPO Game
BioSpace
Fri, 12/28/18 - 01:11 pm
Harpoon Therapeutics
IPOs
tech
A Record Year: A Look at the Biotech IPOs for Q4 2018
BioSpace
Fri, 12/28/18 - 12:57 pm
IPOs
biotech
Moderna Therapeutics
Allogene
Rubius Therapeutics
Kodiak Sciences
Guardant Health
SI Bone
Gossamer Bio Plans to Raise $264.5 Million with IPO
BioSpace
Wed, 12/26/18 - 04:34 pm
Gossamer Bio
IPOs
3 trends in biotech to watch in 2019
Stat
Wed, 12/26/18 - 04:32 pm
biotech
IPOs
Money Keeps Flowing Into Life Science Funds – RiverVest Closes Oversubscribed 184.4 Million Fund
CP Wire
Tue, 12/18/18 - 10:02 am
RiverVest Venture Partners
IPOs
venture capital
Biofrontera cleared of wrongdoing in Nasdaq IPO
Fierce Biotech
Thu, 12/13/18 - 10:10 pm
Biofrontera
IPOs
NASDAQ
Four years after mega IPO, Circassia set for small-cap exchange
Fierce Biotech
Tue, 12/11/18 - 10:24 am
Circassia
IPOs
London
AIM
Nasdaq celebrates record biotech IPO success in 2018. But can the party on Wall Street rumba on?
Endpoints
Mon, 12/10/18 - 09:58 am
IPOs
biotech
NASDAQ
Moderna, largest biotech to go public, fails to impress in market debut
Reuters
Sat, 12/8/18 - 12:29 pm
IPOs
biotech
Moderna Therapeutics
DiaMedica pulls off IPO to fund midphase stroke trial
Fierce Biotech
Fri, 12/7/18 - 10:44 am
IPOs
DiaMedica Therapeutics
chronic kidney disease
acute ischemic stroke
Moderna Raises $604M and Nails Down Biotech’s Biggest IPO Ever
Xconomy
Thu, 12/6/18 - 11:39 pm
IPOs
Moderna Therapeutics
ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later
Xconomy
Thu, 11/29/18 - 12:15 am
ViaCyte
stem cells
diabetes
IPOs
clinical trials
Can a $1B IPO attract leery investors on HKEX? WuXi AppTec is set to find out
Endpoints
Wed, 11/28/18 - 11:58 pm
IPOs
Hong Kong
WuXi AppTec
Can a biotech unicorn break into the record books with a $600M IPO? Stéphane Bancel has a fortune riding on the answer
Endpoints
Wed, 11/28/18 - 11:50 am
Moderna
biotech
IPOs
Stephane Bancel
The flip side of the hot IPO market? A chill could trigger a sudden cash crunch in biotech, followed by more deals
Endpoints
Wed, 11/28/18 - 09:57 am
biotech
IPOs
Genfit plans US listing as NASH drugmakers race to the finish line
Endpoints
Mon, 11/19/18 - 11:44 pm
Genfit
IPOs
NASH
Centrexion steps back from IPO amid volatile market
BioCentury
Sat, 11/17/18 - 12:54 pm
Centrexion
IPOs
Preclinical biotech Synthorx wants a $100M IPO
Fierce Biotech
Wed, 11/14/18 - 11:51 am
IPOs
biotech
Synthorx
immuno-oncology
cytokines
Vapotherm prices $56m IPO
Mass Device
Wed, 11/14/18 - 09:57 am
Vapotherm
IPOs
devices
Moderna aims to raise $500 million in biotech’s largest-ever public offering
Stat
Sat, 11/10/18 - 12:57 pm
Moderna Therapeutics
IPOs
biotech

Pages